Catalyst Wire Dossier Catalyst Wire Dossier

Aldara Imiquimod Cream 5%

Imiquimod · Pharmacia/MedPharm or equivalent brand holder
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aldara Imiquimod Cream 5%, covering 2020-09-04 to 2020-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis [Phase 3]

See pricing